首页> 外文期刊>Journal of oncology pharmacy practice: official publication of the International Society of Oncology Pharmacy Practitioners >Drug-drug interaction related to the use of pipamperon and ondansetron in a child treated for leukemia
【24h】

Drug-drug interaction related to the use of pipamperon and ondansetron in a child treated for leukemia

机译:药物 - 药物相互作用与使用Pipamperon和Ondansetron治疗白血病的儿童

获取原文
获取原文并翻译 | 示例
           

摘要

Pipamperon is a potent neuroleptic drug with many side effects, including prolongation of the QT interval. We report a case of a child treated for leukemia in which prolongation of the QT interval was observed. Physicians and pharmacists should be cautious for drug-drug interactions when pipamperon is prescribed, especially in combination with other QT-prolongating agents. Alternative strategies should be used whenever possible.
机译:Pipamperon是一种具有许多副作用的有效的神经抑制药物,包括QT间隔的延长。 我们举报了对白血病治疗的儿童的病例,其中观察到QT间隔的延长。 当规定潮倾写蛋白时,医生和药剂师应该对药物 - 药物相互作用进行谨慎,特别是与其他QT延时剂组合。 应尽可能使用替代策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号